Migraine--current understanding and treatment.

@article{Goadsby2002MigrainecurrentUA,
  title={Migraine--current understanding and treatment.},
  author={Peter J. Goadsby and Richard B. Lipton and Michel Dominique Ferrari},
  journal={The New England journal of medicine},
  year={2002},
  volume={346 4},
  pages={
          257-70
        }
}
Migraine is a common and sometimes debilitating disorder. This review describes the epidemiology, pathophysiology, and preventive and symptomatic treatment of migraine, with special attention to drug therapy with the triptans. 
View on PubMed
pedclerk.uchicago.edu
1,739 Citations
Highly Influential Citations
60
Background Citations
690
Methods Citations
23
Results Citations
14

Figures and Tables from this paper

1,739 Citations

Migraine update. Diagnosis and treatment.

Current understanding of the mechanisms underlying migraine is reviewed, with neuroimaging used in some cases to exclude secondary causes of headache.

The pharmacological management of migraine, part 1: overview and abortive therapy.

  • G. Demaagd
  • Medicine, Psychology
    P & T : a peer-reviewed journal for formulary management
  • 2008
Part 1 of a two-part series presents a summary of treatments used to reduce the severity and duration of migraine and its associated symptoms and also discusses the comorbidities, clinical presentation, and risk factors associated with this affliction.

Migraine preventive therapy: current and emerging treatment options

This paper starts with an overview about migraine and then briefly discusses current indications for migraine prevention and new and emerging preventive medications.

Prophylactic migraine therapy: Emerging treatment options

Data is presented on topiramate, levetiracetam, zonisamide, botulinim toxin, tizanidine, nefazodone, lisinopril, candesartan, carabersat, petasites, and coenzyme Q.

Combining therapies for the treatment of migraine: is there a role?

Migraine is a highly prevalent disorder mani-festing clinically as headache attacks of moder-ate-to-severe or severe intensity and is usually asso-ciated with nausea, photophobia and phono-phobia.

Neurotoxins in the Neurobiology of Pain

The basic mechanisms of pain are studied to better understand why Migraine is a common, chronic, incapacitating, neurovascular disorder that affects an estimated 12% of the population.

Triptan therapy in migraine.

  • E. Loder
  • Medicine
    The New England journal of medicine
  • 2010
A 23-year-old woman presents with migraine headaches that are unresponsive to analgesics and cardiac ischemia is rare and usually associated with known cardiovascular disease or risk factors.

Methodological Issues in Studying Trigger Factors and Premonitory Features of Migraine

In this review, we focus on migraine as a chronic disorder with episodic attacks (CDEA). We aim to review methodological approaches to studying trigger factors and premonitory features that often…

An Update on Non‐Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine

To review current neuromodulation treatments available for migraine therapy, both in the acute and preventive setting.

Literature Review in Typical Migraine

The format is a general discussion on current theories on migraine pathophysiology, current pharmaceutical therapies and statistics on typical migraine.
...

References

SHOWING 1-10 OF 142 REFERENCES

Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study

Evaluation of the effectiveness of sumatriptan, 50‐mg tablets, versus placebo for early intervention while head pain was mild in patients with disabling migraine found it to be safe and effective.

Sumatriptan for the Range of Headaches in Migraine Sufferers: Results of the Spectrum Study

A small number of patients with a history of migraine and/or episodic tension‐type headaches are diagnosed with atypical or chronic migrainous headaches and receive treatment with anti-inflammatory medication.

Efficacy of Gabapentin in Migraine Prophylaxis

Objective.—To compare gabapentin with placebo for use as a prophylactic agent in patients with migraine (with or without aura).

Migraine Diagnosis and Treatment: Results From the American Migraine Study II

Objective.—A population‐based survey was conducted in 1999 to describe the patterns of migraine diagnosis and medication use in a representative sample of the US population and to compare results…

Medical Consultation for Migraine: Results From the American Migraine Study

In a sample of the US population, this work sought to determine the proportion of active migaineurs who ever consulted a doctor for headache and to identify the headache characteristics and sociodemographic factors associated with consulting.

Drug therapy of migraine.

  • K. Welch
  • Psychology, Medicine
    The New England journal of medicine
  • 1993
The positive (stimulative) followed by negative (suppressive) neurologic symptoms of the aura and the slow spread means that the pathophysiology of migraine is clearly related to disordered brain physiology, although neither the details nor the cause is known.

2: Headache and face pain

General practitioners should be well informed about management, as they are the most appropriate people to deal with most headache patients.

Sumatriptan: A Receptor-Targeted Treatment for Migraine

Clinical data indicate that sumatriptan relieves headache, nausea, and photophobia in a majority of acute migraine patients, and it possesses favorable side effect and safety profiles.

11: Naproxen Sodium in the Treatment of Migraine

Naproxen sodium was much better than placebo when patients' diaries were reviewed for severity of attacks, nausea, vomiting, activity reduction, duration of headache, and decreased use of therapeutic medication.

Ergotamine in the acute treatment of migraine: a review and European consensus.

Ergotamine, from a medical perspective, is the drug of choice in a limited number of migraine sufferers who have infrequent or long duration headaches and are likely to comply with dosing restrictions.
...